Saplid, Baby Girl .
HRN: 22-65-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2023
AMPICILLIN 500MG (VIAL)
05/05/2023
05/11/2023
IVT
130mg
Q12hrs
PSNB (Thickly MSAF)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes